Navigation Links
Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment

A new drug called febuxostat has been found to reduce plasma levels of uric acid more effectively in Gout than the currently used drug allopurinol. If the results of the clinical trial are successful//, then it would mean the end of a 40 year search for successful treatment of Gout.

Gout is characterized by accumulation and deposition of needle shaped uric acid crystals in the joints, thereby leading to inflammation and pain. Progressively, it leads to a condition called ‘Gouty arthritis’ and is associated by a significant reduction in joint mobility.

The only existing standard treatment for Gout is administration of allopurinol, which reduces the levels of uric acid production by blocking certain key steps in uric acid synthesis. In addition, it also decreases the plasma levels of uric acid over a period of time.

The study was conducted amongst a group of 762 patients, diagnosed to suffer from Gout and is believed to be the largest clinical trial ever done on patients with Gout. The mechanism of action of Febuxostat is very similar to allopurinol.

The study participants were either given allopurinol or febuxostat (two different doses) as a form of treatment, the goal of which was to reduce plasma uric acid levels by as much as 6 mg/dl. Allopurinol treatment was taken by 21% of the members, followed by 53 and 62% who took 80 and 120mg of febuxostat respectively.

At the end of the study, it was found that the new drug was more effective than allopurinol when used for more than a year, as revealed by statistical tests. However, a large number of patients were found to discontinue from the study due to the high incidence of adverse effects. The main site of drug metabolism is the liver which facilitates administration of the drug to patients with compromised kidney function as well.

The drug has not yet been approved by the U.S. Food and Drug Administration agency (FDA) for therapeutic use. More studies are
'"/>




Page: 1 2

Related medicine news :

1. Clinical trials need to be more frank
2. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
3. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
4. Clinical Comparisons Between ADHD Drugs Are Less
5. A Novel System For Clinical Banking Of Umbilical Cord Blood
6. Clinical Renal Trails Do Not Have Sufficient Women Participants
7. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
8. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
9. Cancer Clinical Research in India
10. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
11. Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Clinical Trials New Drug Febuxostat Show Promise Gout Treatment

(Date:3/27/2015)... Bleeding is one of the ... intervention (PCI), resulting in increased mortality, morbidity, and ... in which the highest-risk PCI patients with the ... often with bleeding avoidance strategies than lower-risk patients. ... Heart Institute asked the question whether prospectively determining ...
(Date:3/27/2015)... Ticket Down is a reputable source for authentic tickets ... a phenomenal and highly successful live tour last year, the cast ... tour again in 2015 and they will be visiting 8 cities ... in New York City at the cozy Beacon Theatre and will ... 10th. , Fans of the hit show can look forward to ...
(Date:3/27/2015)... Vancouver, BC (PRWEB) March 27, 2015 ... Research ( http://www.idataresearch.com ), the plate and screw market ... sales in the generic plate and screw segment. Price ... device market. Despite representing almost 50% of the total ... projected to decrease the total market value, year after ...
(Date:3/27/2015)... March 27, 2015 The report “CountryFocus: ... essential source of information on and analysis of the ... population of the US in 2013 amounted to 316.1 ... (CAGR) of 0.8% from 2008. The country’s increasingly elderly ... diseases will help to boost the growth of the ...
(Date:3/27/2015)... CA (PRWEB) March 27, 2015 GrassrootsHealth, ... its Protect Our Children (POC) NOW! vitamin D demonstration ... Medical University of South Carolina (MUSC), and will soon ... be available at no cost to a minimum of ... who live within these two service areas. The project ...
Breaking Medicine News(10 mins):Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 2Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 3Health News:Nashville Live in Concert Tickets in New York, Boston, Washington, DC, Chicago, Minneapolis, San Francisco, Los Angeles and Phoenix Now On Sale at TicketDown.com 2Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 2Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 3Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 2Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 3Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 4Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4
... , CHICAGO , Jan. ... the owners of bankrupt Mid-States Express Inc. of Aurora, ... the participants and beneficiaries in the company,s 401(k) and health ... failed to disclose to employees that their medical bills were not likely ...
... might work when unexplained neurologic symptoms occur, researchers ... A combination whole-body PET-CT scan is more accurate ... cancer in patients with neurologic symptoms, according to ... occur in people with lung, breast, ovarian and ...
... PORTLAND, Ore. A new study concludes that many ... Drug Administration warning to screen users of new antipsychotic ... risks to their health and raises questions about the ... analyzed about 109,000 Medicaid patients taking "second generation" antipsychotic ...
... WATERTOWN, Mass. , Jan. 12 Research shows ... also good for the brain, according to the Alzheimer,s Association. ... temperatures to get in shape for the Boston Marathon(R) on ... to keep in shape as well. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20100112/DC36305LOGO ...
... , , ... announces that a new market research report is available in ... http://www.reportlinker.com/p0171106/Diet-Foods--2010-Edition.html , The diet foods market as covered ... have followed different growth paths. The old established low-calorie foods ...
... 12, 2010 -- The American College of Physicians ... ethical relationships among patients, physicians, and caregivers. ... has published "Family Caregivers, Patients and Physicians: Ethical ... online appendix of resources to help physicians manage ...
Cached Medicine News:Health News:U.S. Labor Department sues owners of bankrupt Aurora, Ill., trucking company to recover $3 million in unpaid employee medical claims 2Health News:U.S. Labor Department sues owners of bankrupt Aurora, Ill., trucking company to recover $3 million in unpaid employee medical claims 3Health News:Combo PET-CT Scans Can Spot Hidden Cancers 2Health News:Monitoring of high-risk medications unchanged despite FDA warnings 2Health News:Monitoring of high-risk medications unchanged despite FDA warnings 3Health News:The Run for the Memory Marathon Team Getting in Shape and Fighting Alzheimer's 2Health News:The Run for the Memory Marathon Team Getting in Shape and Fighting Alzheimer's 3Health News:The Run for the Memory Marathon Team Getting in Shape and Fighting Alzheimer's 4Health News:Reportlinker Adds Diet Foods- 2010 Edition 2Health News:Reportlinker Adds Diet Foods- 2010 Edition 3Health News:Reportlinker Adds Diet Foods- 2010 Edition 4Health News:Reportlinker Adds Diet Foods- 2010 Edition 5Health News:Reportlinker Adds Diet Foods- 2010 Edition 6Health News:Reportlinker Adds Diet Foods- 2010 Edition 7Health News:Reportlinker Adds Diet Foods- 2010 Edition 8Health News:Reportlinker Adds Diet Foods- 2010 Edition 9Health News:Reportlinker Adds Diet Foods- 2010 Edition 10Health News:Reportlinker Adds Diet Foods- 2010 Edition 11Health News:Reportlinker Adds Diet Foods- 2010 Edition 12Health News:Reportlinker Adds Diet Foods- 2010 Edition 13Health News:Reportlinker Adds Diet Foods- 2010 Edition 14Health News:New ethical guidance from ACP for patient-physician-caregiver relationship 2
(Date:3/27/2015)... Wis. , March 27, 2015 ... unit shipments of incontinence devices for women. ... but the most gratifying part is the hundreds ... from women whose lives have been positively impacted ... president of InControl. InControl recently released ...
(Date:3/27/2015)... 27, 2015 RnRMarketResearch.com adds ... market research report of 52 pages with latest ... intelligence library. The report "Visceral Pain - Pipeline ... therapeutic development for Visceral Pain, complete with comparative ... target, mechanism of action (MoA), route of administration ...
(Date:3/26/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or ... on Omega-3 therapies for cardiovascular disease and overall health, ... common shares of the Corporation (the "Common Shares"). The ... of December 5 th , 2014 to March 4 ... is due on or before April 1, 2015. Interest ...
Breaking Medicine Technology:InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
... - Millennium on track to file sNDA in ... 18 Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) ... large, international Phase III VISTA(1) trial in,patients with ... of,VELCADE, melphalan and prednisone (VMP) demonstrated a highly ...
... 10 minutes - - Landmark Study Reported in ... 18 A landmark publication that,appeared in the Journal ... site blinded clinical study. The paper is entitled "The ... Accuracy of,Melanoma and Equivocal Melanocytic Lesions." The study, ...
Cached Medicine Technology:Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 2Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 3Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 4Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 5Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 6Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy 2Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy 3
Helmer's Horizon Series line of refrigerators are designed specifically for the cost conscious buyer. This line offers outstanding performance, quality, and the features you need to ensure the safety...
Helmer's Horizon Series line of refrigerator is designed specifically for the cost conscious buyer. This line offers outstanding performance, quality, and the features you need to ensure the safety o...
... Helmer presents ... with innovative solutions for ... more sophisticated features than ... Bank Refrigerators are at ...
... the i.Series refrigerator iB120, ... for the blood bank. ... than ever before, i.Series ... at the forefront of ...
Medicine Products: